Target intelligence / Profile preview

Nucleosome (DNA–histone complex)

Molecular classification
Other, Chromatin structural complex, Epigenetic regulator (structural substrate for histone/DNA modifications)
01

Overview

The DNA–histone complex, canonically termed the nucleosome, is the fundamental unit of eukaryotic chromatin composed of ~146–147 base pairs of DNA wrapped 1.6–1.7 turns around a histone octamer containing two copies each of H2A, H2B, H3, and H4; linker histone H1 binds DNA at the entry/exit to stabilize higher‑order structure. The octamer assembles from an H3–H4 tetramer and two H2A–H2B dimers, with flexible N‑terminal histone tails protruding and undergoing diverse post‑translational modifications that regulate chromatin accessibility and genomic functions including transcription, replication, and repair. While indispensable structurally and functionally, the nucleosome itself is not a discrete drug target like a receptor or enzyme; instead, therapeutic strategies typically address chromatin by modulating histone‑ or DNA‑modifying enzymes, readers, or remodelers, and by using nucleosome‑based biomarkers such as γH2AX to monitor DNA damage responses.

Other names
DNA–histone complexChromatin core particleNucleosome core particle (NCP)Chromatin nucleoprotein complex (contextual)
02

Biological functions

DNA packagingRegulation of chromatin accessibilityGene regulationDNA replicationDNA repairGenome stabilityHigher-order chromatin organization
03

Disease associations

CancerDevelopmental disordersEpigenetic diseasesDNA damage/repair–related pathologies
04

Safety considerations

Targeting the nucleosome globally risks widespread transcriptional dysregulation and DNA damagelack of specificity compared with targeting enzymes/readers/writers of histone or DNA marks
05

Biomarkers

γH2AX (phosphorylated H2AX) as a DNA double‑strand break marker on nucleosomesHistone PTM signatures (e.g., H3K27me3, H3K36me3) measured on nucleosomal chromatin

Beyond the preview

Go deeper on Nucleosome (DNA–histone complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleosome (DNA–histone complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call